Emerging fungal diseases: the importance of the host
- PMID: 15325061
- DOI: 10.1016/j.cll.2004.05.004
Emerging fungal diseases: the importance of the host
Abstract
More yeasts and molds are now recognized to cause more human disease than ever before. This development is not due to a change in the virulence of these fungi, but rather to changes in the human host. These changes include immunosuppression secondary to the pandemic of HIV, the use of life-saving advances in chemotherapy and organ transplantation, and the use of corticosteroids and other immunosuppressive agents to treat a variety of diseases. Fungi that were once considered common saprophytes are now recognized as potential pathogens in these patients. This situation necessitates better communication than ever between the clinician, pathologist, and clinical mycologist to ensure the prompt and accurate determination of the cause of fungal diseases.
Similar articles
-
The changing face of fungal infections in health care settings.Clin Infect Dis. 2005 Nov 15;41(10):1455-60. doi: 10.1086/497138. Epub 2005 Oct 13. Clin Infect Dis. 2005. PMID: 16231257 Review.
-
Emerging fungal diseases.Clin Infect Dis. 2005 Aug 15;41(4):521-6. doi: 10.1086/432060. Epub 2005 Jul 11. Clin Infect Dis. 2005. PMID: 16028162 Review.
-
Emerging fungi.Infect Dis Clin North Am. 2006 Sep;20(3):563-79. doi: 10.1016/j.idc.2006.06.002. Infect Dis Clin North Am. 2006. PMID: 16984869 Review.
-
Emerging fungal infections.Expert Rev Anti Infect Ther. 2012 Apr;10(4):419-21. doi: 10.1586/eri.12.14. Expert Rev Anti Infect Ther. 2012. PMID: 22512751
-
Changing epidemiology of systemic fungal infections.Clin Microbiol Infect. 2008 May;14 Suppl 4:5-24. doi: 10.1111/j.1469-0691.2008.01978.x. Clin Microbiol Infect. 2008. PMID: 18430126 Review.
Cited by
-
Mucosal Candida infection and colonisation as well as associated risk factors in solid organ transplant recipients.Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):945-57. doi: 10.1007/s10096-009-0730-8. Epub 2009 Apr 2. Eur J Clin Microbiol Infect Dis. 2009. PMID: 19340468
-
Protective Efficacy of Lectin-Fc(IgG) Fusion Proteins In Vitro and in a Pulmonary Aspergillosis In Vivo Model.J Fungi (Basel). 2020 Oct 27;6(4):250. doi: 10.3390/jof6040250. J Fungi (Basel). 2020. PMID: 33120893 Free PMC article.
-
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.Infect Drug Resist. 2012;5:9-16. doi: 10.2147/IDR.S22587. Epub 2012 Jan 11. Infect Drug Resist. 2012. PMID: 22294858 Free PMC article.
-
Fungal infection in a patient with multiple sclerosis.Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1173-80. doi: 10.1007/s10096-011-1206-1. Epub 2011 May 1. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21533622
-
Evaluation of molecular diagnostic assays for fungal infections.J Mol Diagn. 2006 Jul;8(3):297-8. doi: 10.2353/jmoldx.2006.060066. J Mol Diagn. 2006. PMID: 16825500 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical